SUMMARY 34 preterm infants with birthweights < 1200 g were randomly assigned to total parenteral nutrition (TPN) or oral (Milk) feeding regimens for the first 2 weeks after birth. Infants in the TPN group were started on a modified Vamin-based glucose amino-acid infusion and Intralipid. The daily amounts of carbohydrate, amino-acids, and fat infusions were increased. In the Milk group, infants were started on intermittent gavage feeding, supplemented with a glucose-electrolyte infusion as necessary. The overall mortality rate did not differ in the two groups. Four infants in the Milk group developed necrotising enterocolitis but none did in the TPN group. Despite mean daily energy intakes which were not greatly different, there were much higher mean daily intakes of carbohydrate and protein in the TPN group compared with the Milk group. Fat intake in the TPN group was lower than in the Milk group in the 1st week because of neonatal jaundice which contraindicated the use of Intralipid. There was no difference in the mean daily fat intake by the 2nd week. Although mean daily weight loss in the 1st week and the maximum postnatal weight loss in the two groups were similar, infants in the TPN group had a greater mean daily weight gain in the 2nd week and took less time to regain and maintain birthweight. Metabolic complications were equally common in both groups and were reversible with early recognition. Limits of tolerance for water and most nutrients tended to be variable and the nutritional programme had to be adjusted for each baby. Nevertheless, we found that TPN, when properly managed, is an effective and safe procedure in very low birthweight infants.
Advances in neonatal intensive care have resulted in better survival of very low birthweight infants. Adequate nutrition in the preterm neonate is considered to be important for immediate survival (Heird et al., 1972b) and for subsequent normal growth and development (Dobbing, 1974) . This need for nutritional support often leads to the overzealous early introduction and excessive increases in volume of milk feeding, with a resulting increased risk of aspiration pneumonia (Wharton and Bower, 1965) , cardiorespiratory disturbances (Yu, 1976) , or necrotising enterocolitis .
Partial parenteral nutrition as a supplement to inadequate oral intake has been used successfully in low birthweight infants (Benda and Babson, 1971; Cashore et al., 1975) (Bryan et al., 1973; Pildes et al., 1973; Brans et al., 1974; Abitbol et al., 1975) . The feasibility of supplying complete requirements with total parenteral nutrition (TPN) via centrally placed catheters has been reported (Driscoll et al., 1972; Peden and Karpel, 1972; MacMahon et al., 1975; Hall and Rhodes, 1976; Meng et al., 1977) . Although most reports claimed benefits with these techniques all but one (Gunn et al., 1978) lacked proper controls. Because complications from intragastric milk feeding will contribute to the morbidity and mortality of very low birthweight infants, a study was accordingly designed to compare TPN with intragastric milk feeding supplemented as necessary with only a glucose-electrolyte solution.
Patients
Infants <1200 g birthweights born, at the Queen Victoria Medical Centre or referred within 24 hours of birth, were considered for the study. After obtaining informed parental consent, the infants were assigned to a feeding regimen of either TPN or intragastric milk feeding (Milk) . Assignment was by random card selection on alternate infants with the infant immediately following qualifying for the opposite study group. 40 infants <1200 g birthweights, admitted to the neonatal intensive care unit during the 12-month period between July 1977 and June 1978, were consecutively enrolled in the study with all babies complying. Six infants died within 24 hours after birth before starting TPN or Milk feeding and were excluded. Therefore, 34 infants were studied.
Methods
Milk group. Intermittent gavage feeding via an orogastric tube was started as soon after birth as the clinical condition of the baby allowed. This was usually begun on day 1 and given every hour using fresh expressed breast milk from the infant's own mother, or a 67 kcal (280 kJ)/100 ml milk formula (Similac, Ross Laboratories, N.S.W., Australia) if the former was unavailable.* The volume of milk was increased as rapidly as tolerated without abdominal distension, gastric retention, or regurgitation. An intake of 150 ml/kg per 24 hours was usually provided but this varied between 100 and 200 ml/kg, depending on the clinical condition of the infant. An infusion of dextrose, water, and electrolytes was supplemented as necessary to maintain normal hydration and biochemical status. The infusate consisted of 5 % dextrose and this was increased to a 10% solution as tolerated. As the oral intake increased, so was the infusion rate decreased. Daily oral multivitamin supplements were given from the 1st week. Any infant in the Milk group who remained nil-orally for more than 3 days after birth or in whom feeds had to be withheld for more than 24 hours subsequently during the 2-week trial period was considered as a trial failure and withdrawn. The subsequent progress of such infants is excluded from the analysis of results. Trial failure infants and infants whose oral intake was <100 kcal/kg on day 14, on completion of the 2-week trial period, were offered parenteral nutrition supplements. TPN group. A glucose amino-acid solution, based on Vamin N (Vitrum, Stockholm, Sweden) with added electrolytes, vitamins, and trace minerals was prepared by the pharmacy according to the programme *Similac has a composition close to that of human breast milk (protein 1-5 g/l00 ml, fat 3-7 g/100 ml, carbohydrate 7-0 g/100 ml) prepared from nonfat cows' milk, vegetable oil, and added lactose.
shown in Table 1 . TPN was prescribed on admission to the study beginning with formula 1A. The glucose infusion rate was increased from 8 to 18 g/kg per 24 hours in daily increments of 2 g/kg by upgrading from formula IA to 3B if hyperglycaemia (blood glucose >11 mmol/l; >198 mg/100 ml) or glycosuria (Clinitest >05%) was not encountered. The programme allowed for an increase in the daily amount of amino-acid infused from 1 to 3 g/kg over 6 days. If there was glucose intolerance, the daily amount of glucose was adjusted, independent of the amino-acid intake. A soybean emulsion (Intralipid 20%, Vitrum, Stockholm, Sweden) was started at a level of 1 g/kg fat per 24 hours after recovery from neonatal jaundice (serum bilirubin <150 ,umol/l (<8 8 mg/100 ml) and falling). This amount was increased, in the absence of visible lipaemia, to a maximum of 3 g/kg per 24 hours. If daily serum specimens showed more than a trace of lipaemia (equivalent to 2 * 8 mmol/l (250 mg/100 ml) triglyceride), lipid intake was reduced. The electrolyte content of the TPN solution was adjusted as shown by the biochemical status. As with infants in the Milk group, an intake of 150 ml/kg per 24 hours was generally provided, but this varied between 100 and 200 ml/kg depending on the clinical condition of the infant.
Infusion technique. TPN and supplemental glucose solutions (in the Milk group) were infused via the indwelling umbilical arterial catheter inserted in infants with respiratory distress or via peripheral veins when the former was not required. Catheter placement was in the descending aorta with the tip Statistical evaluation. Significance of differences between fluid and nutrient intakes and body weight changes in infants on the two feeding regimens was determined using the Mann-Whitney U test.
Results
Clinical data and mortality. No significant difference in birthweights or gestational ages was noted between the 34 infants in the study and the 6 infants who died within 24 hours after birth (Table 2) . Overall mortality for infants <1200 g was 32 5%. (Cashore et al., 1975 (Fig. 2) both groups. In the 2nd week, infants in the Milk group required significantly higher daily mean volume intakes compared with those in the TPN group in order to maintain normal hydration and serum osmolality. Milk provided an average of 62 % of the volume intake on day 7 and 83 % by day 14 (Fig. 1) . With the exception of 3 infants who were fed exclusively on Similac and one infant who died before starting milk feeds, the remaining 13 infants in the Milk group were given fresh expressed breast milk, even though this was often complemented with Similac when the supply of breast milk was interrupted. from hospital. However, 3 of the 10 infants in the Milk group whose oral intake was still under 100 kcal/kg at the end of the 2-week trial were offered parenteral nutrition supplements, and 5 of the 27 survivors were transferred to the referring hospital for convalescent care before discharge. Such comparisons beyond the trial period are therefore difficult to interpret.
Complications. Metabolic disturbances are summarised in Table 7 . Serum hyperosmolality was detected in 4 infants in the TPN group and in 2 in the Milk group. None of these infants developed intracranial haemorrhage. Hyperglycaemia was observed in both groups. All responded promptly to appropriate adjustments in the glucose infusion rate and insulin was not required. Electrolyte 
Discussion
Results are given of a controlled study of 34 critically ill low birthweight infants, half of whom received intragastric milk feeding and, as necessary, IV glucose and electrolyte supplements. The other half received total parenteral nutrition. As the conventional practice is to establish an intra-arterial infusion on admission, infants in the Milk group all had IV glucose which supplemented the fluid and energy intakes during the period in which the volume of milk feeds was increased. It is therefore not possible to obtain a 'pure' milk feed group in infants under 1200 g. However it was considered that a true assessment of the advantages of parenteral nutrition for such infants could be gained only if the latter replaced milk feeding rather than supplemented it. Interpretation of previous reports of total parenteral nutrition is difficult in the absence of adequate controls fed conventionally under identical medical supervision. Studies have been biased by excluding infants with respiratory distress or those who required assisted ventilation (Driscoll et al., 1972; Bryan et al., 1973 ). Yet, these are the very infants who would particularly benefit from more calories and who are most difficult to feed orally. In the present study, infants were randomly assigned to a feeding method and none was excluded after starting the designated regimen. Dweck and Cassady (1974) reported that hyperglycaemia was observed in 86% of very low birthweight infants receiving parenteral glucose. This was reported to be related to high glucose infusion rates exceeding 9*6 g/kg per 24 hours. Accordingly, the TPN regimen was designed to begin with a glucose load of 8 g/kg per 24 hours on day 1. It was possible, however, progressively to increase the mean glucose infusion rate within tolerance limits to 18 g/kg per 24 hours by 7 days after birth. The incidence of hyperglycaemia in the TPN group was similar to that in the Milk group. This complication was resolved by lowering the glucose infusion rate.
Formulated crystalline amino-acid mixtures are more effective than protein hydrolysates as the latter contain considerable amounts of small peptides that are not efficiently used. Of the crystalline amino-acid solutions, Vamin contains only L amino-acid isomers and is more efficiently used with respect to nitrogen metabolism than that containing both the D and L isomers, as in the case of Aminofusin (Pfimmer, Erlangen, West Germany), because of lower urinary amino-acid losses (Hendry et al., 1978) . Furthermore, Vamin maintains serum amino-acid concentrations that are close to normal in small premature infants (Shaw et al., 1977) , whereas Aminofusin seriously disrupts normal amino-acid concentrations (Kellerman et al., 1976) . The recommended dose of 3 g of amino-acids (equivalent approximately to 2 * 6 g protein)/kg per 24 hours given in this study, using Vamin as the nitrogen source, is based on work previously carried out here (Kellerman et al., 1976; Shaw et al., 1977; Hendry et al., 1978) . Heird et al. (1972a) suggested that the metabolism of excessive cationic amino-acids results in excess of hydrogen ion which leads to metabolic acidosis during parenteral nutrition. The incidence of this complication was low and similar in the TPN and Milk groups.
[t is possible that the acetate in the TPN solution acts as a bicarbonate precursor and is capable of buffering the excess hydrogen ion formed. Hyperammonaemia observed in infants given parenteral nutrition has been attributed to high ammonia content in protein hydrolysates or to inadequate arginine in the crystalline amino-acid solution (Heird et al., 1972c; Johnson et al., 1972) . This complication was not observed in this study.
Less mature infants had a poorer Intralipid tolerance initially, as was observed by Shennan et al. (1977) . However, most infants tolerated 3 g/kg fat per 24 hours by the 2nd week as had been shown previously (Cashore et al., 1975; Gunn et al., 1978) . It has been noted, however, that some infants on Intralipid can develop high plasma levels of free fatty acids which can interfere with bilirubinalbumin binding and thus increase the risk of bilirubin encephalopathy (Andrew et al., 1976) . As we had no method for monitoring the effects of free fatty acids on bilirubin-albumin binding, it was decided that an increasing serum bilirubin level, or one >150 ,umol/l, is a contraindication for Intralipid. This was found to occur in all the infants in this series within the first 5 days, thus contributing to the insufficient energy intake in the TPN group during this early period. Adequate monitoring of the Intralipid-bilirubin relationship by determining the reserve bilirubin-binding capacity or by calculating the free fatty acids to albumin molar ratio will provide a safety index for Intralipid use in the presence of neonatal jaundice.
The introduction of neonatal intensive care has led to a decrease in the mortality rate of very low birthweight infants (Stewart et al., 1977) . At the Queen Victoria Medical Centre, infants weighing <1000 g had over 80% mortality in the 3 years 1970 3 years to 1972 3 years (MacMahon et al., 1975 , whereas the mortality rates for those weighing 501 to 1000 g and 1001 to 1500 g were 52 and 20% respectively during 1977 (Yu and Wood, 1978) . The reason for this improvement in outlook is obviously multifactorial, of which early adequate nutrition provided by safer methods is only one factor. An effect upon mortality can only be formally demonstrated by a carefully controlled study. However, it is impossible to isolate this one factor in the very low birthweight infant in whom the mortality will, in any case, be high. As in the one previous report of TPN versus a control group managed with the conventional feeding regimen (Gunn et al., 1978) , no statistically significant differences in mortality rate between the two groups could be shown. One factor which is not comparably matched in the two groups is the sex of the infants. The fact that there were 10 girls in the Milk group compared with 6 in the TPN group suggests that the Milk group was more favourably placed, allowing for the expected male preponderance in mortality.
Infants in the TPN group had earlier and greater weight gain than those in the Milk group, despite similar total caloric intake. Oral nutrients are poorly absorbed in preterm infants. The energy need in achieving weight gain observed in the present study is in agreement with that by Cashore et al. (1975) who reported that most infants gained weight at the expected rate of fetal growth in utero (20 g per day at 28 weeks and 30 g per day at 34 weeks) when the desired energy intake of 90 kcal(380 kJ)/kg per 24 hours of parenteral nutrition or 120 kcal(500 kJ)/kg per 24 hours of milk feeding was attained. Furthermore, the nitrogen intake of the Milk group was significantly lower than that of the TPN group for the duration of the study. In the 2nd week, the TPN group achieved the recommended parenteral nitrogen requirement of Vamin-fed preterm infants (Hendry et al., 1978) of 30 mmol/kg nitrogen per 24 hours, equivalent to 3 1 g of amino-acids or 2 6 g/kg protein per 24 hours. The latter study also showed that only 80% of the oral nitrogen intake in these Similac-fed infants was absorbed, which put the infants in the Milk group at a further disadvantage. It has nevertheless been suggested that the faster weight gain observed in parenterally supplemented infants compared with their orally-fed controls might be attributable to water retention rather than to more rapid tissue accretion (Brans et al., 1976) ; but in that study, there was no difference in daily protein intake between the two groups. Firm conclusions must await further studies, including concomitant estimates of total and extracellular body water.
Comparison of the morbidity in the two groups showed that no baby in the TPN group had necrotising enterocolitis whereas 4 infants in the Milk group developed this during the first 2 weeks, one of whom died despite surgical intervention for intestinal perforation. Enteric feeding, particularly for babies with mucosal ischaemia, was thought to be of aetiological significance in the development of necrotising enterocolitis . This has to be considered as a significant morbidity associated with milk feeding in very low birthweight infants in addition to the more commonly described aspiration pneumonia for which there was also one example in the Milk group in the present study. The incidence of intraventricular haemorrhage was similar in the two groups. None of the 5 infants with this complication had serum hyperosmolality but 4 of them, 2 in each group, had blood glucose levels >11 mmol/l. A further 11 infants were found to have transient hyperglycaemia but did not develop intraventricular haemorrhage. Though TPN in this study has not been shown to increase the incidence ofhyperosmolality or hyperglycaemia compared with milk feeding, the clinical implication of hyperglycaemia in intraventricular haemorrhage needs further study.
Metabolic complications were relatively common, but in no case were these persistent or considered to have resulted in serious consequences. The number of recorded disturbances could be attributed to the fact that the infants were closely monitored. Constant laboratory support, using microtechniques, was needed for early diagnosis so that rapid adjustments in the composition of the infusate could be made. However, it is reasonably certain that if monitoring had been less thorough or if a 'standard' mixture had been used, serious and perhaps fatal metabolic complications could have ensued.
This controlled study has shown a more adequate nitrogen intake and an improved weight gain, an avoidance of necrotising enterocolitis, but an unchanged mortality rate in very low birthweight infants managed with TPN compared with conventional milk feeding during the first 2 weeks after birth. Complications which could be specifically assigned to TPN were few. The possibility that TPN may be responsible for intrahepatic cholestasis in some very low birthweight infants is being investigated. Long-term studies ofneurological, intellectual, and behavioural development are needed and are currently in progress. 
